Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) comes as a pre-filled KwikPen. The injection needles are already attached and covered inside the device — you do not buy or fit separate needles for the standard pen. Each pen contains four weekly doses, delivered via a built-in needle that engages automatically when you press the pen against your skin. As a prescription-only medicine, Mounjaro must be prescribed following a clinical assessment; the pen and its needle mechanism are described in full in the Patient Information Leaflet supplied with your treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Take your Mounjaro pen out of the fridge and let it sit at room temperature for a few minutes. Cold medicine injected straight from the fridge can sting more than it needs to. Check the medicine through the viewing window: it should be clear or slightly yellow, with no particles or cloudiness. If something looks off, do not use that dose, contact your prescriber.
Mounjaro can be injected into the abdomen, the front of the thigh, or the upper arm. Rotate your injection site each week; returning to exactly the same spot can cause the skin to harden over time, which may affect how the medicine is absorbed. The full guide to the Mounjaro injection process covers site rotation in more detail.
Clean the chosen area with an alcohol swab and allow it to dry fully, injecting through wet skin increases the risk of irritation. You can find suitable alcohol swabs designed for this purpose if your supply is running low. Once the skin is dry you are ready to proceed.
Remove the base cap from the pen. You will see the needle cover, do not pull this off manually; the mechanism is designed to work when the pen is pressed flush against clean, dry skin. Hold the pen at a 90-degree angle to the skin and press it down firmly until you feel it click into position.
Press and hold the injection button. Keep the pen pressed against your skin for the full duration indicated on the pen (typically around ten seconds), releasing early can mean not all of the dose is delivered. You will hear or feel a second click when the dose is complete. Lift the pen away cleanly; the needle retracts automatically and the window will change colour to confirm a full dose was given.
If you are unsure whether you received the full dose, do not inject again without speaking to your prescriber first. Duplicate dosing is not the right response to uncertainty. A question our prescribers hear regularly is whether a partial dose can simply be topped up, the answer is always: check with your clinical team before doing anything.
Once the needle has retracted, the pen is locked and cannot be reused. It must go into a rigid, puncture-proof sharps container rather than a bin bag or cardboard recycling. This is not a preference, it is a legal requirement under UK clinical waste regulations, and it protects refuse workers and others from accidental needle-stick injury.
A one-litre sharps container is large enough for most people's Mounjaro pens and sits neatly in a bathroom cupboard. When it reaches the fill line, your local pharmacy or GP surgery can advise on approved disposal routes; many councils operate sharps collection schemes too. Never put a used pen (even with the needle retracted) in household waste.
For more context on the pen format, injection needles, and what the different doses look like, the Mounjaro injection needle overview and the guide to needles for Mounjaro pens both go into further detail. If you are comparing what comes in each pen across different suppliers, the UK-specific pen and needle information page is a useful starting point.
Counterfeit tirzepatide pens have been seized in the UK in significant quantities; some contained entirely different substances. If your pen looks different from others in the same batch (different cap colour, unusual resistance when pressed, a needle cover that detaches on its own) do not use it. The MHRA encourages reporting of suspected fake medicines via the Yellow Card scheme, and the NHS tirzepatide information page describes what a genuine pen should look and feel like.
Buying from a pharmacy you can verify on the GPhC register is the simplest protection against counterfeit product. The needles for tirzepatide injection page includes more on identifying genuine supply and what to do if you have concerns. For background on how the cost of legitimate treatment is structured, the Mounjaro price guide explains what a genuine prescription-based service includes. If you are already on treatment and have further questions, the faqs page covers the queries our team hears most often.
If you have not yet started Mounjaro and want to explore whether it may be clinically suitable for you, check your eligibility with a free consultation, reviewed the same day by a GPhC-registered prescriber, not software.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.